News
Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates
Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to a loss of $2 per share a year ago
Red Robin (RRGB) Reports Q3 Loss, Beats Revenue Estimates
Red Robin (RRGB) came out with a quarterly loss of $0.7 per share versus the Zacks Consensus Estimate of a loss of $0.78. This compares to a loss of $1.13 per share a year ago. These figures are
TransAct Technologies Incorporated (TACT) Reports Break-Even Earnings for Q3
TransAct Technologies Incorporated (TACT) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.06 per share a year
Oculis Holding AG (OCS) Reports Q3 Loss, Beats Revenue Estimates
Oculis Holding AG (OCS) came out with a quarterly loss of $0.4 per share versus the Zacks Consensus Estimate of a loss of $0.5. This compares to a loss of $0.55 per share a year ago. These figures
PubMatic, Inc. (PUBM) Q3 Earnings and Revenues Surpass Estimates
PubMatic, Inc. (PUBM) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to earnings of $0.12 per share a year ago
Chegg (CHGG) Reports Break-Even Earnings for Q3
Chegg (CHGG) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to earnings of $0.09 per share a year ago. These figures are
The Beachbody Company, Inc. (BODI) Q3 Earnings and Revenues Beat Estimates
The Beachbody Company, Inc. (BODI) came out with quarterly earnings of $0.51 per share, beating the Zacks Consensus Estimate of a loss of $0.54 per share. This compares to a loss of $1.75 per share
Quest Resource (QRHC) Reports Q3 Loss, Beats Revenue Estimates
Quest Resource (QRHC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of $0.01. This compares to a loss of $0.16 per share a year ago. These figures are
Quanterix Corporation (QTRX) Reports Q3 Loss, Tops Revenue Estimates
Quanterix Corporation (QTRX) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to a loss of $0.22 per share a year ago. These
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Beats Revenue Estimates
Arcturus Therapeutics (ARCT) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $1.25. This compares to a loss of $0.26 per share a year ago. These
Ascend Wellness Holdings, Inc. (AAWH) Reports Q3 Loss, Lags Revenue Estimates
Ascend Wellness Holdings, Inc. (AAWH) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.13 per share a year ago
Stocks to Watch for the First Trillion Dollar Holiday Shopping Season
With Black Friday approaching at the end of the month, savvy investors may be eying the retail sector for the possibility of lucrative returns. To that point, the day after Thanksgiving will
Quality Over Hype: Investing Wisely for the Long Term
- (1:00) - Breaking Down The Most Recent Earnings Results From Technology Stocks
- (5:00) - Should Investors Be Concerned With The Recent Shorting In AI Stocks?
- (9:40) - Is The Stock Market Due For A
Nuclear Stocks Are Melting Down—Should Investors Panic?
Last week, on the news that Michael Burry, the renowned investor of The Big Short fame, had put options on NVIDIA (NASDAQ: NVDA) and—more significantly—Palantir Technologies (NASDAQ: PLTR), tech
XPENG Breaks Out as Deliveries Surge & AI Vision Expands
XPENG Company Overview
Zacks Rank #3 (Hold) stock XPENG (XPEV) is a leading Chinese electric vehicle manufacturer. Founded in 2014, XPEV designs, develops, and manufactures “smart EVs” aimed at
S&P 500's Top Stock Lifts Dividend 25%, KGC & MPC Raise Payouts
Several market-beating stocks just announced significant dividend increases. These stocks are all outperforming the 16% return of the S&P 500 Index by at least two to one in 2025. Multiple are up
3 Top Ranked Momentum Stock to Buy Now (LRCX, TER, DINO)
Volatility has returned to the market in recent weeks, and last week’s sharp selloff briefly reignited fears of a market top. As usual, the bears grew loud during the pullback, but those concerns
Top Research Reports for Accenture, Sanofi & Dell Technologies
Monday, November 10, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Accenture
AI Stock Correction: MSFT, AVGO, IONQ Seen as Stable Tech, Quantum Bets
In early November 2025, U.S. equities experienced a notable sell-off in the technology and AI space. The Nasdaq Composite recorded its steepest weekly decline since April as investors questioned the
3 Breakout Stocks Active Investors Should Buy for a Strong Portfolio
An active investing strategy includes detecting breakout stocks trading within a specific price range. Investors usually sell when the price falls below the lower band and hold onto positions when
Why Many Market Analysts Are Keeping A Close Eye On Gaming
Monday.com Opens Generational Opportunity With Manic Sell-Off
Monday.com’s (NASDAQ: MNDY) Q3 earnings release provided an excuse to sell, but the 20% decline posted in premarket action is an overreaction of epic proportions. The cause was guidance. The
Do Options Traders Know Something About Penumbra Stock We Don't?
Investors in Penumbra, Inc. PEN need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $125 Put had some of the highest implied
Are Options Traders Betting on a Big Move in Pebblebrook Hotel Stock?
Investors in Pebblebrook Hotel Trust PEB need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $5 Put had some of the highest
Making Sense of the Market's Tech Worries
The recent pullback in leading artificial intelligence stocks has rekindled concerns about the group’s stock price momentum and market leadership. The absence of economic data due to the government


